UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of August 2022

 

Commission File Number: 001-39738

 

UCOMMUNE INTERNATIONAL LTD

(Exact name of registrant as specified in its charter)

 

Floor 8, Tower D

No. 2 Guang Hua Road
Chaoyang District, Beijing

People’s Republic of China, 100026

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F     Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation ST Rule 101(b)(1): Not Applicable

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation ST Rule 101(b)(7): Not Applicable

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Consent and Waiver

 

On August 1, 2022, Ucommune International Ltd (the “Company”) and JAK Opportunities LLC (the “Purchaser”) entered into a consent and waiver (“Consent and Waiver”). The Purchaser is a holder of the debenture of the Company issued pursuant to the securities purchase agreement dated January 26, 2022 (the “Securities Purchase Agreement”), as amended on March 1, 2022, and the debenture, dated January 26, 2022 (the “Debenture”), as amended on March 1, 2022, to which the Company is a party. Pursuant to the Consent and Waiver, the Purchaser consented to, and waived all rights to which it may be entitled under the Securities Purchase Agreement, Debenture and other related transaction documents in connection with, the Company’s amending its Amended and Restated Memorandum and Articles of Association to state that each Class B ordinary share, par value of $0.002 per share, of the Company shall be entitled to 35 votes on all matters subject to vote at general and special meetings of the Company.

 

The foregoing summary of the Consent and Waiver does not purport to be complete and is qualified in its entirety by reference to the full text of this document. Copy of the Consent and Waiver is attached hereto as Exhibit 99.1, which is incorporated herein by reference.

 

Incorporation by Reference

 

This current report on Form 6-K (“this report”) and Exhibit 99.1 to this report are incorporated by reference into the registration statement on Form F-3 of Ucommune International Ltd (File No. 333-257664) and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Safe Harbor Statements

 

This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potential,” “continue,” “ongoing,” “targets,” “guidance” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s growth strategies; its future business development, results of operations and financial condition; its ability to understand members’ needs and provide products and services to attract and retain members; its ability to maintain and enhance the recognition and reputation of its brand; its ability to maintain and improve quality control policies and measures; its ability to establish and maintain relationships with members and business partners; trends and competition in China’s agile office space market; changes in its revenues and certain cost or expense items; the expected growth of China’s agile office space market; PRC governmental policies and regulations relating to the Company’s business and industry, and general economic and business conditions in China and globally and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this report and in the attachments is as of the date of this report, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

 

1

 

 

EXHIBIT INDEX

 

Exhibit   Description
99.1   Consent and Waiver dated August 1, 2022

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  UCOMMUNE INTERNATIONAL LTD
   
  By: /s/ Xin Guan
    Xin Guan 
CEO 

 

Date: August 3, 2022

 

[Signature Page to Form 6-K]

 

3

 

 

Exhibit 99.1 

 

CONSENT AND WAIVER

 

August 1, 2022

 

Reference is made to (i) the Securities Purchase Agreement, dated January 26, 2022 (the “Securities Purchase Agreement”), between Ucommune International Ltd (the “Company”) and JAK Opportunities LLC (the “Purchaser”), as the purchaser named therein, as amended on March 1, 2022, and (ii) the Debenture, dated January 26, 2022 (the “Debenture”), between the Company and the Purchaser, as the holder named thereof, as amended on March 1, 2022. Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Securities Purchase Agreement.

 

WHEREAS, the Company desires to amend its Amended and Restated Memorandum and Articles of Association to state that each Class B Ordinary Share shall be entitled to 35 votes on all matters subject to vote at general and special meetings of the Company (the “Voting Ratio Amendment”);

 

WHEREAS, pursuant to Section 4.17 of the Securities Purchase Agreement, the Company shall not, without the prior written consent of holders of a majority in principal amount outstanding of the Debentures, undertake any action which alters or amends its amended and restated articles of association; and

 

WHEREAS, pursuant to Section 7(c) of the Debenture, as long as any portion of the Debenture remains outstanding, unless the holders of at least 50% in principal amount of the then outstanding Debentures shall have otherwise given prior written consent, the Company shall not, and shall not permit any of the Subsidiaries to, directly or indirectly, amend its charter documents, including, without limitation, its certificate of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Purchaser;

 

NOW THEREFORE, the Purchaser hereby consents to, and waives all rights to which it may be entitled under the Transaction Documents in connection with, the Voting Ratio Amendment, including with respect to Section 4.17 of the Securities Purchase Agreement and Section 7(c) of the Debenture.

 

The Transaction Documents and this consent and waiver shall be read together and shall have the same effect as if the Transaction Documents and this consent and waiver were contained in one agreement. Except as expressly modified by this consent and waiver, the terms and obligations of the Transaction Documents remain unchanged and the Transaction Documents shall continue in full force and effect.

 

This consent and waiver shall be governed by, construed and enforced in accordance with, the laws of the State of New York, without regard to the conflict of laws principles thereof.

 

 

 

 

If you are in agreement with the foregoing, please have this consent and waiver executed by your authorized representative and return a copy to the undersigned.

 

  UCOMMUNE INTERNATIONAL LTD
     
  By: /s/ Daqing Mao
  Name: Daqing Mao
  Title: Director

 

Confirmed and Agreed:  
     
JAK Opportunities LLC  
     
By: /s/ Antonio Ruiz-Gimenez  
Name:  Antonio Ruiz-Gimenez  
Title: Managing Member